FULL-TEXT ARTICLE
Optimizing adherence in HIV
prevention product trials:
Development and psychometric
evaluation of simple tools for
screening and adherence
counseling
Tolley EE, Guthrie KM, Zissette
S, et al
PLoS
One.
2018 Apr 12
Paper
FULL-TEXT ARTICLE
Ending the HIV/AIDS Pandemic
Eisinger RW, Fauci AS.
Emerg Infect Dis.
2018 Mar;24(3):413-416
Paper
The MEDIA model: An innovative
method for digitizing and
training community members to
facilitate an HIV prevention
intervention.
Renfro T, Johnson E, Lambert DN,
et
al
Transl Behav Med.
2018 Feb 17.
Abstract
Genotypic and
Phylogenetic Insights on
Prevention of the Spread of
HIV-1 and Drug Resistance in
"Real-World" Settings.
Brenner BG, Ibanescu RI, Hardy
I, Roger M.
Viruses. 2017 Dec
28;10(1).
Abstract
CROI 2017: HIV Epidemic Trends
and Advances in Prevention.
Liu AY, Buchbinder SP.
Top Antivir Med.
2017 May/Jun;25(2):35-50.
Abstract
Web and Mobile
Based HIV Prevention and
Intervention Programs Pros and
Cons - A Review.
Niakan S, Mehraeen E, Noori T,
Gozali E.
Stud Health Technol Inform.
2017;236:319-32
Abstract
Systemic
and topical use of monoclonal antibodies to prevent the sexual transmission
of HIV.
Anderson DJ, Politch JA, Zeitlin L,
et al
AIDS.
2017 May 1
Abstract
Examining the Acceptability of mHealth Technology in HIV
Prevention Among High-Risk Drug Users in Treatment.
Shrestha R, Huedo-Medina TB, Altice FL,
et al
AIDS Behav.
2016 Dec 26.
Abstract
FULL-TEXT ARTICLE
Human Resources for Treating HIV/AIDS: Are the Preventive Effects of
Antiretroviral Treatment a Game Changer?
Bärnighausen T, Bloom DE, Humair S.
PLoS One.
2016 Oct 7;11(10):e0163960.
Paper
FULL-TEXT ARTICLE
How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of
Experts' Opinion and Its Influence on the Projected Public Health Impact.
Dimitrov DT, Boily MC, Hallett TB, et al
PLoS One. 2016 Jul 8;11(7):e0158620.
.
Paper
Maximising HIV prevention by balancing the opportunities of today
with the promises of tomorrow: a modelling study.
Smith JA, Anderson SJ, Harris KL, et
al
Lancet HIV.
2016 Jul;3(7):e289-96.
Abstract
Antiretroviral Therapy for Prevention of Human Immunodeficiency Virus Infection.
Kalapila AG, Marrazzo J.
Med Clin North Am. 2016 Jul;100(4):927-950.
Abstract
To Use a Rectal Microbicide, First Insert the Applicator: Gel and Applicator
Satisfaction Among Young Men Who Have Sex With Men.
Bauermeister J, Giguere R, Dolezal C,
et al;
AIDS Educ Prev.
2016 Feb;28(1):1-10.
Abstract
FULL-TEXT ARTICLE
Optimizing HIV prevention for women: a review of
evidence from microbicide studies and
considerations for gender-sensitive microbicide
introduction.
Doggett EG, Lanham M, Wilcher R,
et al
J Int AIDS Soc.
2015 Dec 21;18(1):20536
Paper
Considerations for a Human Rights
Impact Assessment of a Population Wide Treatment
for HIV Prevention Intervention.
Hanefeld J, Bond V, Seeley J,
et al
Dev World Bioeth.
2015 Dec;15(3):115-124. d
Abstract
Integrating Antiretroviral
Strategies for Human Immunodeficiency Virus
Prevention: Post- and Pre-Exposure Prophylaxis
and Early Treatment.
Grant RM, Smith DK.
Open Forum Infect Dis.
2015 Aug 26;2(4):ofv126.
Abstract
The Rational Design and
Development of A Dual Chamber Vaginal/Rectal
Microbicide Gel Formulation for HIV Prevention.
Ham AS, Nugent ST, Peters JJ, et al
Antiviral Res.
2015 Jun 17
Abstract
The Strategic Use of Antiretrovirals to Prevent
HIV Infection: A Converging Agenda.
Baggaley R, Doherty M, Ball A, et al
Clin Infect Dis.
2015 Jun 1;60 Suppl 3:S159-60.
Abstract
HIV prevention and treatment strategies can help address the
overdose crisis.
Walley AY.
Prev Med. 2015 Apr 17
Abstract
FULL-TEXT ARTICLE
HIV Treatment-As-Prevention Research: Taking the Right Road at the
Crossroads.
Hayes R, Fidler S, Cori A, et al
PLoS Med. 2015 Mar
10;12(3):e1001800.
Paper
FULL-TEXT ARTICLE
HIV Treatment-As-Prevention Research: Authors' Reply.
Bärnighausen T, Eyal N, Wikler D
PLoS Med.
2015 Mar 10;12(3):e1001799.
Paper
Predicting time to threshold for initiating antiretroviral
treatment to evaluate cost of treatment as HIV prevention.
Lynch ML, DeGruttola V.
J R Stat Soc Ser C Appl Stat.
2015 Feb 1;64(2):359-375.
Abstract
Barrier Methods for Human Immunodeficiency Virus Prevention.
Eaton EF, Hoesley CJ.
Infect Dis Clin North Am.
2014 Dec;28(4):585-599
Abstract
Collaboration With Urban Parents to Deliver a Community-Based Youth HIV
Prevention Program.
Chowdhury J, Alicea S, Jackson JM,
et al
Fam Soc.
2013;94(3):150-156.
Abstract
Clinical Trial Design for HIV Prevention Research: Determining Standards of
Prevention.
Dawson L, Zwerski S.
Bioethics. 2014 Sep 17.
Abstract
Pre-exposure prophylaxis does not affect the fertility of HIV-1-uninfected
men.
Were EO, Heffron R, Mugo NR, et al
AIDS. 2014 Aug
24;28(13):1977-1982
Abstract
Combination HIV prevention for female sex workers: what is
the evidence?
Bekker LG, Johnson L, Cowan F, et al
Lancet. 2014 Jul 21. pii: S0140-6736(14)60974-0
Abstract
A Paradigm Shift: Focus on the HIV Prevention Continuum.
McNairy ML, El-Sadr WM.
Clin Infect Dis. 2014 Jul 1;59 Suppl 1:S12-5
Abstract
Who Pays and Why? Costs, Effectiveness, and Feasibility of HIV Treatment as
Prevention.
Wilson D, Fraser N.
Clin Infect Dis. 2014 Jul
1;59 Suppl 1:S28-31.
Abstract
Treatment as prevention: arriving at community consensus.
Cairns G, Baker AC, Dedes N, et al
Clin Infect Dis. 2014 Jul 1;59
Suppl 1:S35-40.
Abstract
Global Response to HIV: Treatment as Prevention, or Treatment for Treatment?
Sigaloff KC, Lange JM, Montaner J.
Clin Infect Dis. 2014 Jul 1;59
Suppl 1:S7-S11
Abstract
FULL-TEXT ARTICLE
HIV Treatment-as-Prevention Research at a Crossroads.
Bärnighausen T, Eyal N, Wikler D.
PLoS Med. 2014 Jun
3;11(6):e1001654.
Paper
Estimating the effectiveness in HIV prevention trials by incorporating the
exposure process: Application to HPTN 035 data.
Zhang J, Brown ER.
Biometrics. 2014 May 20.
Abstract
The Global HIV Archive: Facilitating the Transition from Science
to Practice of Efficacious HIV Prevention Interventions.
Card JJ, Newman EN, Golden RE, et al
World J AIDS. 2013 Mar;3(1):41-
Abstract
Vaginal microbicides and their delivery platforms.
D'Cruz OJ, Uckun FM.
Expert Opin Drug Deliv.
2014 Feb 8.
Abstract
A Systematic Review of Microfinance-Based Interventions for HIV/AIDS Prevention.
Arrivillaga M, Salcedo JP.
AIDS Educ Prev. 2014 Feb;26(1):13-27.
Abstract
Antiretroviral therapy for the prevention of HIV transmission: What will it
take?
McNairy ML, El-Sadr WM.
Clin Infect Dis. 2014
Jan 14
Abstract
Systematic Assessment of Condom Use Measurement in Evaluation
of HIV Prevention Interventions: Need for Standardization of Measures.
Fonner VA, Kennedy CE, O'Reilly
KR, Sweat MD.
AIDS Behav.
2013 Nov 7
Abstract
Adherence to Antiretroviral Therapy for the Success of
Emerging Interventions to Prevent HIV Transmission: A Wake up Call.
Nachega JB, Uthman OA, Mills EJ, Quinn TC.
J AIDS Clin Res. 2013 Oct
22;2012(Suppl 4).
Abstract
Setting the Bar High or Setting Up to Fail? Interpretations
and Implications of The EXPLORE Study (HPTN 015).
Kalichman SC, Zohren L, Eaton LA.
AIDS Behav. 2013 Aug 30.
Abstract
Preparing for the Unexpected: The Pivotal Role of Social and
Behavioral Sciences in Trials of Biomedical HIV Prevention Interventions.
Koblin BA, Andrasik M, Austin J.
J Acquir Immune Defic Syndr. 2013
Jul;63 Suppl 2:S183-6.
Abstract |
New
and Noteworthy 
Global
Challenges
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader